Drug-drug interactions between vitamin K antagonists and statins: a systematic review
Drug-drug interactions between vitamin K antagonists and statins: a systematic review
Engell et al., 2021 | Eur J Clin Pharmacol | Systematic Review
Citation
Engell Anna E, Svendsen Andreas L O, ... Pottegård Anton. Drug-drug interactions between vitamin K antagonists and statins: a systematic review. Eur J Clin Pharmacol. 2021-Oct;77(10):1435-1441. doi:10.1007/s00228-020-03074-w
Abstract
PURPOSE: Concomitant use of vitamin K antagonists (VKA) and statins is frequent in cardiovascular patients. However, clinical guidelines on this drug combination are divergent. Therefore, we performed a systematic review to evaluate the effect of statin initiation on coagulation among VKA users. METHODS: Following the PRISMA guidelines, we applied two broad search strategies for the drug interaction between VKA and statins in both Embase and Pubmed; 8623 unique hits were obtained. In the final sample, eight studies were included. RESULTS: The most frequently used VKA in the studies was warfarin, while simvastatin was the most commonly initiated statin. All included studies showed a minor increase in the anticoagulant effect of VKA following statin initiation during VKA treatment. The reported increases in mean international normalized ratio (INR) ranged from 0.15-0.65. CONCLUSION: The anticoagulant effect of statin initiation in patients treated with VKA is likely to be of limited clinical relevance but should be evaluated individually.
Key Findings
The most frequently used VKA in the studies was warfarin, while simvastatin was the most commonly initiated statin. All included studies showed a minor increase in the anticoagulant effect of VKA following statin initiation during VKA treatment. The reported increases in mean international normalized ratio (INR) ranged from 0.15-0.65.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | See abstract |
| Sample Size | See abstract |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Anticoagulants
- Blood Coagulation
- Drug Interactions
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- International Normalized Ratio
- Vitamin K
- Warfarin
Evidence Classification
- Level: Systematic Review
- Publication Types: Journal Article, Systematic Review
- Vertical: vitamin-k
Provenance
- PMID: 33895864
- DOI: 10.1007/s00228-020-03074-w
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09